TrialDiabetes, obesity & metabolism2022

Effects of 26 weeks of treatment with empagliflozin versus glimepiride on the myocardial glucose metabolic rate in patients with type 2 diabetes: The randomized, open-label, crossover, active-comparator FIORE trial.

Elena Succurro et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.